Retatrutide 40mg*10vials

描述

Core Features
$\ge 99.0\%$ Purity & High-Capacity Stability Control: This product is manufactured using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Given Retatrutide’s complex heterogeneous peptide chain structure and the exceptionally high 40mg fill weight per vial, the synthesis and purification processes present significant technical challenges. We employ precise industrial-grade reversed-phase preparative HPLC (RP-HPLC) to rigorously eliminate by-products such as racemates, truncated chains, and mis-sequences. Each 40mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic studies.
Synergistic Triple-Agonist Mechanism: Retatrutide is a standout molecule in metabolic research, capable of binding with high affinity to three key metabolic receptors: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). Its unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving the synergistic downregulation of appetite, delayed gastric emptying, promotion of white adipose tissue browning, and upregulation of overall energy expenditure.

Advanced Cryo-Lyophilization Process: The 40mg high-concentration peptide powder undergoes moisture sublimation at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free snowflake-like crystalline solid cake. This process not only ensures excellent reconstitution properties—allowing for dissolution within seconds using sterile water for injection or normal saline, resulting in a clear, bubble-free solution—but also stabilizes the molecule’s secondary structure. This significantly mitigates the risks of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Parameter | Specification Details
Product Specification | 40 mg / Vacuum-Sealed Glass Vial
Molecular Formula | $\text{C}_{211}\text{H}_{342}\text{N}_{54}\text{O}_{68}$
Appearance | White to off-white sterile lyophilized powder / intact solid cake
Validation | Accompanied by original manufacturer HPLC purity chromatograms and MS molecular weight verification reports (one certificate per vial; supports digital traceability and batch verification against manufacturer records).

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions that ensure protection from light and moisture, alongside a high-vacuum seal. Storage in standard household appliances or office equipment lacking temperature logging capabilities is strictly prohibited. Due to the high 40 mg dosage and susceptibility to degradation post-reconstitution, researchers are strongly advised to aliquot the product based on single-dose animal administration requirements and freeze the aliquots; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” protocols. 40mg Retatrutide is shipped using high-density, thickened five-layer insulated foam boxes combined with high-capacity, phase-change gel packs via express delivery. This ensures that the peptide molecule’s complex spatial conformation remains “locked” in a stable state while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Retatrutide 40mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or biopharmaceutical R&D centers (e.g., cell receptor binding affinity assays, metabolic obesity model monitoring in rodents or non-human primates). Any unauthorized human clinical use—including injection, oral administration, substitution for prescribed medication, or use as an illicit weight-loss agent or performance-enhancing drug—is strictly prohibited. This platform enforces a rigorous “End-Use Statement” verification process; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.